Resmed Inc Stock In The News

RMD Stock  USD 180.35  1.50  0.84%   
The overall news coverage of ResMed Inc from major news outlets shows bullish sentiment on 10 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of ResMed's news coverage and content from conventional and social sources shows investors' bearish mood towards ResMed Inc. The specific impact of ResMed news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ResMed's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ResMed headlines in addition to utilizing other, more conventional financial analysis modules. Check out ResMed Backtesting and ResMed Hype Analysis.

ResMed Today Top News and Investor Outlook

Yahoo News
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://finance.yahoo.com/news/resmed-rmd-earnings-expected-grow-140138320.html
 Bullish
Yahoo News
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
https://finance.yahoo.com/m/91581473-8b5f-359a-a88d-dfb507774b6c/eli-lilly-pops-after.html
 Bearish
Yahoo News
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61%
https://finance.yahoo.com/news/resmed-inc-nyse-rmd-favorite-164809496.html
 Bullish
Investors Business Daily at Macroaxis
Here's Why Investors Should Buy ResMed (RMD) Stock Now
https://finance.yahoo.com/news/heres-why-investors-buy-resmed-164400714.html
 Bullish
Yahoo News
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
https://finance.yahoo.com/news/resmeds-2024-global-sleep-survey-070500140.html
 Neutral
Yahoo News
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://finance.yahoo.com/news/momentum-investor-1-stock-could-145009388.html
 Bullish
Yahoo News
ResMed (RMD) Debuts the Smallest Full-Face CPAP Mask AirFit F40
https://finance.yahoo.com/news/resmed-rmd-debuts-smallest-full-123300377.html
 Bullish
Yahoo News
Introducing the AirFit F40: Experience U...
https://finance.yahoo.com/news/introducing-airfit-f40-experience-unprecedented-140500242.html
 Bullish
Yahoo News
ResMed Inc Director Peter Farrell Sells 23,535 Shares
https://finance.yahoo.com/news/resmed-inc-director-peter-farrell-081024124.html
 Bullish
Yahoo News
Why Is ResMed (RMD) Down 1.7% Since Last Earnings Report?
https://finance.yahoo.com/news/why-resmed-rmd-down-1-163030223.html
 Bullish

ResMed Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ResMed and other traded companies coverage. We help investors stay connected with ResMed headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on ResMed Stock performance. Please note that trading solely based on the ResMed Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
ResMed's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help ResMed Inc investors visualize upcoming and past events in order to time the market based on ResMed Inc noise-free hype analysis.
ResMed stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ResMed earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ResMed that are available to investors today. That information is available publicly through ResMed media outlets and privately through word of mouth or via ResMed internal channels. However, regardless of the origin, that massive amount of ResMed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ResMed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ResMed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ResMed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ResMed alpha.

ResMed Largest EPS Surprises

Earnings surprises can significantly impact ResMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2004-02-04
2003-12-310.090.10.0111 
2003-08-05
2003-06-300.090.10.0111 
2003-04-22
2003-03-310.080.090.0112 
2001-05-01
2001-03-310.050.060.0120 
2000-10-31
2000-09-300.040.050.0125 
2000-05-02
2000-03-310.040.050.0125 
View All Earnings Estimates

ResMed Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ResMed Inc Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
18th of April 2024
ASX snaps five-day losing streak
at au.finance.yahoo.com 
benzinga news
17th of April 2024
ResMed Unusual Options Activity For April 17
at benzinga.com 
news
16th of April 2024
Resmed CDI stock and Woolworths Group Ltd shares are 2 ASX shares to watch
at raskmedia.com.au 
benzinga news
15th of April 2024
Heres How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
at benzinga.com 
fool News
11th of April 2024
3 unexpected ASX shares owned by top-performing fund managers
at fool.com.au 
Yahoo News
10th of April 2024
CHILDRENS WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
at finance.yahoo.com 
benzinga news
8th of April 2024
Jim Cramer Isnt Going With This Tech Company Its Complicated. Im A Nvidia Guy
at benzinga.com 
Macroaxis News
18th of March 2024
Disposition of 200 shares by Michael Rider of ResMed at 173.25 subject to Rule 16b-3
at MacroaxisInsider 
fool News
8th of March 2024
Up 37 percent from their low Can ResMed shares keep rising
at fool.com.au 

ResMed Investors Sentiment

The influence of ResMed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ResMed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ResMed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ResMed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ResMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ResMed's short interest history, or implied volatility extrapolated from ResMed options trading.
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.05
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.